During the 2026 J.P. Morgan Healthcare Conference, Novavax CEO John C. Jacobs outlined a transformative roadmap designed to evolve the... Read more
Tag: #Global Trends
Enanta Pharmaceuticals targets leadership in RSV treatment landscape
During the 44th Annual J.P. Morgan Healthcare Conference in January 2026, Enanta Pharmaceuticals detailed its strategic focus on developing oral... Read more
AbbVie successfully pivots to multi-franchise growth model post-Humira
At the 44th Annual J.P. Morgan Healthcare Conference in January 2026, AbbVie presented a comprehensive update on its strategic evolution.... Read more
Novartis urges global leaders to redefine life sciences within trade frameworks
A collaborative open letter from Novartis and the Eurasia Group has called on world governments to address the growing "G-Zero"... Read more
New clinical data highlights efficacy of J&J’s multiple myeloma monotherapy
Johnson & Johnson (J&J) has released positive top-line results from the phase 3 MajesTEC-9 trial, demonstrating the effectiveness of Tecvayli... Read more
Phase 3 clinical trial findings for Epkinly in diffuse large B-cell lymphoma
Latest data from the Epcore DLBCL-1 clinical study indicates that Epkinly did not meet its primary endpoint of overall survival... Read more
Google’s MedGemma 1.5 and MedASR set new benchmarks in medical AI
Technology Spotlight As part of its "Health AI Developer Foundations" program, Google Research has officially released a dual-model open AI... Read more
Novartis and AstraZeneca drive new deals at JPM 2026
Conference Updates The second day of the industry's premier healthcare event in San Francisco continued to showcase strong investment in... Read more
Anthropic unveils “Claude for Healthcare” to rival ChatGPT at JPM 2026
HealthTech News At the 2026 J.P. Morgan Healthcare Conference, Anthropic officially launched Claude for Healthcare, a comprehensive suite of AI... Read more









